Keep pulling the thread on Bloomberg Intelligence.
Eli Lilly has agreed to acquire three vaccine developers in a deal valued at as much as $3.8 billion.
Eli Lilly became the first healthcare company to achieve a $1 trillion market valuation last year.
Quantinuum aims to raise approximately $1 billion in its IPO, targeting a market capitalization of around $12 billion to $13 billion.
The Trump administration announced $2 billion in funding for quantum computing companies on May 21st.
SpaceX is expected to launch its IPO marketing campaign on the day following the pricing of Quantinuum's IPO.
Craig Trudell reports there is speculation from sources close to Elon Musk that the SpaceX IPO could be a precursor to an eventual merger with Tesla.
The upcoming World Cup is projected to generate an economic impact of $80 billion in global spending.
Adidas management has publicly stated they expect the World Cup to generate €1 billion in revenue for the company.
Eli Lilly has a significant amount of cash on hand due to the commercial success of its blockbuster obesity and diabetes medications.
Eli Lilly is pursuing acquisitions to build its next phase of growth in anticipation of its current blockbuster drugs losing patent protection.
Eli Lilly hired former FDA official Peter Marks last year to lead its infectious disease unit.
Eli Lilly's M&A strategy favors acquiring earlier-stage companies for cheaper deals over pursuing larger, later-stage mergers.